(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Allergy Therapeutics PLC on Wednesday said its combined phases 1 and 2a trial shows its potential treatment for peanut allergy supports a "strong immunomodulating potential" for the product. Read More
(Alliance News) - Allergy Therapeutics PLC shares declined on Monday, despite the firm saying it expects to report increased revenue for its first half. Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Allergy Therapeutics PLC on Thursday said it is preparing to evaluate a dual primary listing on the Main Board of The Stock Exchange of Hong Kong Ltd. Read More
(Alliance News) - AstraZeneca reports higher earnings, J Sainsbury raises its profit guidance and interim dividend while ITV warns of a tough advertising market. Read More
(Alliance News) - Allergy Therapeutics PLC said on Thursday that the trial of its short-course peanut allergy vaccine candidate VLP Peanut has had "positive progress" in phase 1 and phase 2a. Read More
(Alliance News) - Allergy Therapeutics PLC on Monday said it expects to report a small decline in earnings during its most recent financial year, as a result of regulatory changes within its key German market. Read More
(Alliance News) - European equities were muted at the market open on Monday, beaten by the FTSE 100 as the index passed the 9,000 mark on a boost from miners. Read More
(Alliance News) - Allergy Therapeutics PLC on Monday said talks are underway regarding further financing as it said reduced costs helped trim its half-year loss. Read More
